Insulin resistance, characterized by the reduced responsiveness of peripheral tissues, particularly skeletal muscles and adipose tissues, to insulin, is a central feature of metabolic syndrome pathophysiology and is an early event in the development of cardiovascular disease and type 2 diabetes (T2D) in humans [2,3]. Here, INS is linked to type 2 diabetes mellitus.